Raj Prabhakar
Corporate Officer/Principal at ROCKET PHARMACEUTICALS, INC.
Net worth: - $ as of 2024-04-29
Profile
Raj Prabhakar is currently the Chief Business Officer & Senior Vice President at Rocket Pharmaceuticals, Inc. Prior to his current position, he held the role of Executive Director-Business Development at Imunon, Inc. from 2004 to 2015.
Following that, he served as the Senior Vice President-Business Development at Caladrius Biosciences, Inc. from 2015 to 2017.
Mr. Prabhakar completed his undergraduate studies at Massachusetts Institute of Technology and holds an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-23 | 0 ( -.--% ) | - $ | 2024-04-29 |
Raj Prabhakar active positions
| Companies | Position | Start |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-09-30 |
Former positions of Raj Prabhakar
| Companies | Position | End |
|---|---|---|
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 2017-09-30 |
| IMUNON, INC. | Corporate Officer/Principal | 2015-06-30 |
Training of Raj Prabhakar
| Massachusetts Institute of Technology | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IMUNON, INC. | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
- Stock Market
- Insiders
- Raj Prabhakar